Published in Clinical Oncology Week, February 28th, 2005
Rohn was most recently at Biogen Idec where he served as the chief operating officer (COO) since the merger of IDEC Pharmaceuticals Corporation and Biogen, Inc. in November 2003. Prior to the merger, he served as president and COO for IDEC Pharmaceuticals.
"We are very pleased to have Rohn join our board of directors. We are confident that his extensive experience in building a leading biotechnology company from research to commercialization will prove invaluable for Raven," said Jennie Mather, PhD, president and CEO of Raven....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.